LifeStance Health Group, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

LFST$14.60+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Balance Sheets

(In thousands, except for par value)

	March 31, 2026	December 31, 2025
CURRENT ASSETS
Cash and cash equivalents	$194,797	$248,642
Patient accounts receivable, net	122,916	95,710
Prepaid expenses and other current assets	38,198	71,848
Total current assets	355,911	416,200
NONCURRENT ASSETS
Property and equipment, net	161,468	161,583
Right-of-use assets	151,526	149,720
Intangible assets, net	175,141	177,665
Goodwill	1,296,999	1,293,346
Other noncurrent assets	4,837	5,419
Total noncurrent assets	1,789,971	1,787,733
Total assets	$2,145,882	$2,203,933
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable	$4,292	$6,122
Accrued payroll expenses	117,306	143,327
Other accrued expenses	52,408	42,187
Operating lease liabilities, current	47,369	45,544
Other current liabilities	18,357	14,782
Total current liabilities	239,732	251,962
NONCURRENT LIABILITIES
Long-term debt, net	262,459	265,927
Operating lease liabilities, noncurrent	148,821	148,553
Deferred tax liability, net	16,408	16,408
Other noncurrent liabilities	1,046	68
Total noncurrent liabilities	428,734	430,956
Total liabilities	$668,466	$682,918
COMMITMENTS AND CONTINGENCIES (see Note 12)
STOCKHOLDERS’ EQUITY
Preferred stock – par value $0.01 per share; 25,000 shares authorized as of March 31, 2026 and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025	—	—
Common stock – par value $0.01 per share; 800,000 shares authorized as of March 31, 2026 and December 31, 2025; 387,813 and 388,318 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	3,878	3,883
Additional paid-in capital	2,267,921	2,325,758
Accumulated deficit	(794,383)	(808,626)
Total stockholders' equity	1,477,416	1,521,015
Total liabilities and stockholders’ equity	$2,145,882	$2,203,933

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.